StockIQpro
NASDAQ:SNGX

Soligenix, Inc.

Soligenix, Inc. reported net income of −$11.1M in fiscal 2025. Free cash flow was −$10.3M, and the diluted share count rose 212.5%.Summary generated from Soligenix, Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.

Revenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−235.5%
Debt / equityn/a
Free cash flow−$10.3M
FCF marginn/a
Share count change+212.5%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue1110n/a
Operating income−13−14−8−9−12
Net income−13−14−6−8−11
Free cash flown/an/an/an/a−10

Recent filings

From SEC EDGAR

Peers

Pharmaceutical preparations